JP2010533737A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010533737A5 JP2010533737A5 JP2010517201A JP2010517201A JP2010533737A5 JP 2010533737 A5 JP2010533737 A5 JP 2010533737A5 JP 2010517201 A JP2010517201 A JP 2010517201A JP 2010517201 A JP2010517201 A JP 2010517201A JP 2010533737 A5 JP2010533737 A5 JP 2010533737A5
- Authority
- JP
- Japan
- Prior art keywords
- vlp
- protein
- vzv
- influenza
- tegument
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000623 proteins and genes Proteins 0.000 claims 17
- 102000004169 proteins and genes Human genes 0.000 claims 17
- 241000701085 Human alphaherpesvirus 3 Species 0.000 claims 10
- 206010022000 influenza Diseases 0.000 claims 5
- 241000712461 unidentified influenza virus Species 0.000 claims 4
- 101710154606 Hemagglutinin Proteins 0.000 claims 3
- 102000005348 Neuraminidase Human genes 0.000 claims 3
- 108010006232 Neuraminidase Proteins 0.000 claims 3
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 3
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 3
- 101710176177 Protein A56 Proteins 0.000 claims 3
- 239000000185 hemagglutinin Substances 0.000 claims 3
- 239000011159 matrix material Substances 0.000 claims 3
- 230000001086 cytosolic effect Effects 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 108700010900 influenza virus proteins Proteins 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000013598 vector Substances 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95070707P | 2007-07-19 | 2007-07-19 | |
| US97059207P | 2007-09-07 | 2007-09-07 | |
| US7183508P | 2008-05-20 | 2008-05-20 | |
| PCT/US2008/070636 WO2009012487A2 (en) | 2007-07-19 | 2008-07-21 | Chimeric varicella zoster virus-virus like particles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010533737A JP2010533737A (ja) | 2010-10-28 |
| JP2010533737A5 true JP2010533737A5 (enExample) | 2011-08-11 |
Family
ID=40260107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010517201A Withdrawn JP2010533737A (ja) | 2007-07-19 | 2008-07-21 | キメラ水痘帯状疱疹ウイルス−ウイルス様粒子 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20110008838A1 (enExample) |
| EP (3) | EP2540312B1 (enExample) |
| JP (1) | JP2010533737A (enExample) |
| CN (1) | CN101801411A (enExample) |
| CA (1) | CA2693899A1 (enExample) |
| CY (1) | CY1116583T1 (enExample) |
| DK (1) | DK2540312T3 (enExample) |
| ES (1) | ES2542644T3 (enExample) |
| HR (1) | HRP20150758T1 (enExample) |
| HU (1) | HUE025702T2 (enExample) |
| PL (1) | PL2540312T3 (enExample) |
| PT (1) | PT2540312E (enExample) |
| SI (1) | SI2540312T1 (enExample) |
| WO (2) | WO2009012487A2 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3067064T (pt) | 2008-12-09 | 2020-06-16 | Novavax Inc | Proteínas f vsr modificadas e processos para a sua utilização |
| US11446374B2 (en) | 2008-12-09 | 2022-09-20 | Novavax, Inc. | Modified RSV F proteins and methods of their use |
| EP2952581A1 (en) * | 2009-05-01 | 2015-12-09 | Redbiotec AG | Recombinant virus-like particles encoded by multi-gene vector |
| PL222497B1 (pl) | 2009-06-26 | 2016-08-31 | Inst Biochemii I Biofizyki Pan | Wektorowa cząsteczka wirusopodobna, sposób jej wytwarzania, kompozycja farmaceutyczna oraz zastosowanie wektorowej cząsteczki wirusopodobnej |
| AU2010266129B2 (en) | 2009-07-02 | 2016-04-14 | Massachusetts Institute Of Technology | Compositions and methods for diagnosing and/or treating influenza infection |
| US9708373B2 (en) | 2010-03-30 | 2017-07-18 | Icahn School Of Medicine At Mount Sinai | Influenza virus vaccine and uses thereof |
| AU2011305371B2 (en) | 2010-09-21 | 2015-05-21 | Massachusetts Institute Of Technology | Human-adapted HA polypeptides, vaccines, and influenza treatment |
| CN103328002B (zh) | 2010-10-04 | 2020-01-14 | 麻省理工学院 | 血球凝集素多肽以及与其相关的试剂和方法 |
| TWI526539B (zh) * | 2010-12-22 | 2016-03-21 | 苜蓿股份有限公司 | 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp |
| CN107090463A (zh) * | 2011-01-31 | 2017-08-25 | 宾夕法尼亚大学托管会 | 编码新型疱疹抗原的核酸分子、包含所述核酸分子的疫苗及其使用方法 |
| WO2013043729A1 (en) | 2011-09-20 | 2013-03-28 | Mount Sinai School Of Medicine | Influenza virus vaccines and uses thereof |
| KR20140077169A (ko) * | 2011-09-30 | 2014-06-23 | 노바백스, 인코포레이티드 | 호흡기 세포 융합 바이러스에 대한 재조합 나노입자 ｒｓｖ ｆ 백신 |
| WO2013112690A1 (en) * | 2012-01-24 | 2013-08-01 | Universtiy Of Georgia Research Foundation, Inc. | Piv5 as oncolytic agent |
| EP2934581B1 (en) | 2012-12-18 | 2022-09-14 | Icahn School of Medicine at Mount Sinai | Influenza virus vaccines and uses thereof |
| RU2015138530A (ru) * | 2013-02-11 | 2017-03-20 | Новавакс, Инк. | Комбинированная вакцина против респираторно-синцитиального вируса и вируса гриппа |
| US9908930B2 (en) | 2013-03-14 | 2018-03-06 | Icahn School Of Medicine At Mount Sinai | Antibodies against influenza virus hemagglutinin and uses thereof |
| AU2016209032A1 (en) | 2015-01-23 | 2017-08-10 | Icahn School Of Medicine At Mount Sinai | Influenza virus vaccination regimens |
| EP3344291B1 (en) | 2015-09-03 | 2024-11-27 | Novavax, Inc. | Vaccine compositions having improved stability and immunogenicity |
| EP3471767A4 (en) | 2016-06-15 | 2020-01-15 | Icahn School of Medicine at Mount Sinai | Influenza virus hemagglutinin proteins and uses thereof |
| EP3606555A4 (en) | 2017-04-07 | 2021-08-04 | Icahn School of Medicine at Mount Sinai | INFLUENZA VIRUS TYPE B ANTI-NEURAMINIDASE ANTIBODIES AND THEIR USES |
| CN111148509A (zh) | 2017-07-24 | 2020-05-12 | 诺瓦瓦克斯股份有限公司 | 治疗呼吸系统疾病的方法和组合物 |
| SG11202009206QA (en) | 2018-03-19 | 2020-10-29 | Novavax Inc | Multivalent influenza nanoparticle vaccines |
| EP3810634A4 (en) | 2018-06-21 | 2022-07-27 | Icahn School of Medicine at Mount Sinai | Mosaic influenza virus hemagglutinin polypeptides and uses thereof |
| CN110237248A (zh) * | 2019-07-01 | 2019-09-17 | 大连民族大学 | 一种带状疱疹疫苗的制备方法 |
| JP2023530445A (ja) * | 2020-06-17 | 2023-07-18 | メイッサ ヴァクシーン，インコーポレイテッド | キメラｒｓｖおよびコロナウイルスタンパク質、免疫原性組成物、ならびに使用方法 |
| GB202017649D0 (en) * | 2020-11-09 | 2020-12-23 | Autolus Ltd | Polypeptide |
| KR102680105B1 (ko) * | 2021-05-17 | 2024-07-02 | 대한민국 | 코로나19 바이러스 및 인플루엔자 h1n1 바이러스에 대한 바이러스 유사입자 및 이의 용도 |
| WO2024153235A1 (zh) * | 2023-01-19 | 2024-07-25 | 厦门大学 | 一种水痘-带状疱疹病毒gE和gI的融合蛋白及应用 |
| CN116284455B (zh) * | 2023-04-17 | 2024-10-11 | 北京康乐卫士生物技术股份有限公司 | 一种带状疱疹病毒疫苗的嵌合抗原及其应用 |
| CN120418435A (zh) * | 2023-11-13 | 2025-08-01 | 石药集团巨石生物制药有限公司 | 一种抵抗带状疱疹的mRNA疫苗及其制备方法 |
| CN120020142A (zh) * | 2023-11-20 | 2025-05-20 | 上海蓝鹊生物医药有限公司 | 一种vzv抗原变体、核酸、药物组合物及其应用 |
| CN119684476B (zh) * | 2025-02-21 | 2025-05-06 | 中国医学科学院医学生物学研究所 | 一种抗水痘-带状疱疹病毒单克隆抗体及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4877611A (en) | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
| US4911928A (en) | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
| US6387373B1 (en) | 1993-01-15 | 2002-05-14 | Novavax, Inc. | Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants |
| US5629021A (en) | 1995-01-31 | 1997-05-13 | Novavax, Inc. | Micellar nanoparticles |
| WO2003068804A2 (en) | 2002-02-14 | 2003-08-21 | Novavax, Inc. | Novel insect cell line |
| US8592197B2 (en) * | 2003-07-11 | 2013-11-26 | Novavax, Inc. | Functional influenza virus-like particles (VLPs) |
| MXPA04010902A (es) * | 2004-11-03 | 2006-05-08 | Alvaro Raul Lara Rodriguez | Vacuna recombinante a partir de las proteinas ge, gi y gb del virus de varicela zoster como tratamiento y prevencion de esclerosis multiple. |
| US7951384B2 (en) * | 2005-08-05 | 2011-05-31 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
| JP5714799B2 (ja) * | 2005-10-18 | 2015-05-07 | ノババックス インコーポレイテッド | 機能的インフルエンザウイルス様粒子（ｖｌｐ） |
-
2008
- 2008-07-21 JP JP2010517201A patent/JP2010533737A/ja not_active Withdrawn
- 2008-07-21 WO PCT/US2008/070636 patent/WO2009012487A2/en not_active Ceased
- 2008-07-21 WO PCT/US2008/070638 patent/WO2009012489A1/en not_active Ceased
- 2008-07-21 US US12/669,703 patent/US20110008838A1/en not_active Abandoned
- 2008-07-21 SI SI200831460T patent/SI2540312T1/sl unknown
- 2008-07-21 PL PL12185712T patent/PL2540312T3/pl unknown
- 2008-07-21 CA CA 2693899 patent/CA2693899A1/en not_active Abandoned
- 2008-07-21 EP EP20120185712 patent/EP2540312B1/en active Active
- 2008-07-21 EP EP08782139A patent/EP2176427A4/en not_active Withdrawn
- 2008-07-21 HU HUE12185712A patent/HUE025702T2/en unknown
- 2008-07-21 EP EP08796367A patent/EP2175883A4/en not_active Withdrawn
- 2008-07-21 CN CN200880108050A patent/CN101801411A/zh active Pending
- 2008-07-21 DK DK12185712.2T patent/DK2540312T3/en active
- 2008-07-21 PT PT121857122T patent/PT2540312E/pt unknown
- 2008-07-21 ES ES12185712.2T patent/ES2542644T3/es active Active
-
2015
- 2015-07-09 HR HRP20150758TT patent/HRP20150758T1/hr unknown
- 2015-07-14 CY CY20151100613T patent/CY1116583T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010533737A5 (enExample) | ||
| JP2013216685A5 (enExample) | ||
| Liu et al. | Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins | |
| JP2019011344A5 (enExample) | ||
| EP3199545A3 (en) | Computationally optimized broadly reactive antigens for h1n1 influenza | |
| WO2008148104A8 (en) | Novel vlps derived from cells that do not express a viral matrix or core protein | |
| MX346905B (es) | Produccion de particulas similares a virus en plantas. | |
| JP2015119730A5 (enExample) | ||
| JP2011182797A5 (enExample) | ||
| WO2017136575A1 (en) | Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites | |
| NZ597401A (en) | Chimeric influenza virus-like particles comprising hemagglutinin | |
| JP2012095652A5 (enExample) | ||
| JP2012511579A5 (enExample) | ||
| JP2013533745A5 (enExample) | ||
| JP2010533001A5 (enExample) | ||
| NZ587108A (en) | Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin | |
| JP2006230415A5 (enExample) | ||
| JP2013517773A5 (enExample) | ||
| MY161965A (en) | New influenza virus immunizing epitope | |
| HK1203524A1 (en) | Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses | |
| Chen et al. | Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic | |
| AU2024200382A1 (en) | Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites | |
| ZA202100386B (en) | Influenza virus hemagglutinin mutants | |
| AU2013352179A8 (en) | Computationally optimized broadly reactive antigens for H1N1 influenza | |
| JP2020533966A5 (enExample) |